Pharmacologic treatment in pediatric functional abdominal pain disorders: A systematic review

Journal of Pediatrics

Volumn 166, Issue 2, 2015, Pages 424-431.e6

  Korterink, Judith J ^a   Rutten, Juliette M T M ^a   Venmans, Leonie ^b   Benninga, Marc A ^a   Tabbers, Merit M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Paediatric Association of the Netherlands   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIARRHEAL AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIMIGRAINE AGENT; ANTIREFLUX AGENT; CYPROHEPTADINE; EMETIC AGENT; FAMOTIDINE; GASTROINTESTINAL AGENT; LAXATIVE; MACROGOL; MACROGOL 3350; PEPPERMINT OIL; PLACEBO; SPASMOLYTIC AGENT; TEGASEROD; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ARTICLE; COCHRANE LIBRARY; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG WITHDRAWAL; FATIGUE; HEADACHE; HUMAN; MEDLINE; PAIN INTENSITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; SCORING SYSTEM; SYSTEMATIC REVIEW; ADOLESCENT; CHILD; COMPLICATION; GASTROINTESTINAL DISEASE; PRESCHOOL CHILD;

ABDOMINAL PAIN; ADOLESCENT; CHILD; CHILD, PRESCHOOL; GASTROINTESTINAL DISEASES; HUMANS;

EID: 84921492449     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.09.067     Document Type: Article

References (70)

1. A. Rasquin, C. Di Lorenzo, D. Forbes, E. Guiraldes, J.S. Hyams, and A. Staiano Childhood functional gastrointestinal disorders: child/adolescent Gastroenterology 130 2006 1527 1537
2. D.K. Chitkara, D.J. Rawat, and N.J. Talley The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review Am J Gastroenterol 100 2005 1868 1875
3. H. Helgeland, G. Flagstad, J. Grotta, P.O. Vandvik, H. Kristensen, and T. Markestad Diagnosing pediatric functional abdominal pain in children (4-15 years old) according to the Rome III Criteria: results from a Norwegian prospective study J Pediatr Gastroenterol Nutr 49 2009 309 315
4. A. Caplan, L. Walker, and A. Rasquin Validation of the pediatric Rome II criteria for functional gastrointestinal disorders using the questionnaire on pediatric gastrointestinal symptoms J Pediatr Gastroenterol Nutr 41 2005 305 316
5. L.S. Walker, T.A. Lipani, J.W. Greene, K. Caines, J. Stutts, and D.B. Polk Recurrent abdominal pain: symptom subtypes based on the Rome II Criteria for pediatric functional gastrointestinal disorders J Pediatr Gastroenterol Nutr 38 2004 187 191
6. J.V. Schurman, C.A. Friesen, C.E. Danda, L. Andre, E. Welchert, and T. Lavenbarg Diagnosing functional abdominal pain with the Rome II criteria: parent, child, and clinician agreement J Pediatr Gastroenterol Nutr 41 2005 291 295
7. N.N. Youssef, T.G. Murphy, A.L. Langseder, and J.R. Rosh Quality of life for children with functional abdominal pain: a comparison study of patients' and parents' perceptions Pediatrics 117 2006 54 59
8. N.N. Youssef, K. Atienza, A.L. Langseder, and R.S. Strauss Chronic abdominal pain and depressive symptoms: analysis of the national longitudinal study of adolescent health Clin Gastroenterol Hepatol 6 2008 329 332
9. G. Dhroove, A. Chogle, and M. Saps A million-dollar work-up for abdominal pain: is it worth it? J Pediatr Gastroenterol Nutr 51 2010 579 583
10. D.A. Drossman The functional gastrointestinal disorders and the Rome III process Gastroenterology 130 2006 1377 1390
11. N.A. Koloski, M. Jones, J. Kalantar, M. Weltman, J. Zaguirre, and N.J. Talley The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study Gut 61 2012 1284 1290
12. A.A. Lebel Pharmacology J Pediatr Gastroenterol Nutr 47 2008 703 705
13. D.A. Drossman, M. Camilleri, E.A. Mayer, and W.E. Whitehead AGA technical review on irritable bowel syndrome Gastroenterology 123 2002 2108 2131
14. J.V. Campo, C. Di Lorenzo, L. Chiappetta, J. Bridge, D.K. Colborn, and J.C. Gartner Jr. Adult outcomes of pediatric recurrent abdominal pain: do they just grow out of it? Pediatrics 108 2001 E1
15. M.J. Gieteling, S.M. Bierma-Zeinstra, J. Passchier, and M.Y. Berger Prognosis of chronic or recurrent abdominal pain in children J Pediatr Gastroenterol Nutr 47 2008 316 326
16. A. Huertas-Ceballos, S. Logan, C. Bennett, and C. Macarthur Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood Cochrane Database Syst Rev 2008 CD003017
17. G.H. Guyatt, A.D. Oxman, G.E. Vist, R. Kunz, Y. Falck-Ytter, and P. Alonso-Coello GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 2008 924 926
18. J.P. Higgins, D.G. Altman, P.C. Gotzsche, P. Juni, D. Moher, and A.D. Oxman The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 343 2011 d5928
19. H.J. Schünemann, A.D. Oxman, G.E. Vist, J.P. Higgins, J.J. Deeks, and P. Glasziou Interpreting results and drawing conclusions J.P.T. Higgins, S. Green, Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 2011 The Cochrane Collaboration http://www.cochrane-handbook.org Accessed November 4, 2014
20. A. Kaminski, A. Kamper, K. Thaler, A. Chapman, and G. Gartlehner Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescents Cochrane Database Syst Rev 2011 CD008013
21. V. Khoshoo, C. Armstead, and L. Landry Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome Aliment Pharmacol Ther 23 2006 191 196
22. M. Sadeghian, F. Farahmand, G.H. Fallahi, and A. Abbasi Cyproheptadine for the treatment of functional abdominal pain in childhood: a double-blinded randomized placebo-controlled trial Minerva Pediatr 60 2008 1367 1374
23. D.N. Symon, and G. Russell Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine Arch Dis Child 72 1995 48 50
24. R.M. Kline, J.J. Kline, J. Di Palma, and G.J. Barbero Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children J Pediatr 138 2001 125 128
25. R.J. Bahar, B.S. Collins, B. Steinmetz, and M.E. Ament Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents J Pediatr 152 2008 685 689
26. M. Saps, N. Youssef, A. Miranda, S. Nurko, P. Hyman, and J. Cocjin Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders Gastroenterology 137 2009 1261 1269
27. M.C. See, A.H. Birnbaum, C.B. Schechter, M.M. Goldenberg, and K.J. Benkov Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment Dig Dis Sci 46 2001 985 992
28. R. Khanna, J.K. Macdonald, and B.G. Levesque Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis J Clin Gastroenterol 48 2014 505 512
29. A.C. Ford, N.J. Talley, B.M. Spiegel, A.E. Foxx-Orenstein, L. Schiller, and E.M. Quigley Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis BMJ 337 2008 a2313
30. D. Lesbros-Pantoflickova, P. Michetti, M. Fried, C. Beglinger, and A.L. Blum Meta-analysis: the treatment of irritable bowel syndrome Aliment Pharmacol Ther 20 2004 1253 1269
31. M. Hawthorn, J. Ferrante, E. Luchowski, A. Rutledge, X.Y. Wei, and D.J. Triggle The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations Aliment Pharmacol Ther 2 1988 101 118
32. H.W. Nolen III, and D.R. Friend Menthol-beta-D-glucuronide: a potential prodrug for treatment of the irritable bowel syndrome Pharm Res 11 1994 1707 1711
33. J. Westphal, M. Horning, and K. Leonhardt Phytotherapy in functional upper abdominal complaints Results of a clinical study with a preparation of several plants Phytomedicine 2 1996 285 291
34. T. Poynard, S. Naveau, B. Mory, and J.C. Chaput Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome Aliment Pharmacol Ther 8 1994 499 510
35. M. Darvish-Damavandi, S. Nikfar, and M. Abdollahi A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome World J Gastroenterol 16 2010 547 553
36. J.V. Schurman, H.L. Hunter, and C.A. Friesen Conceptualization and treatment of chronic abdominal pain in pediatric gastroenterology practice J Pediatr Gastroenterol Nutr 50 2010 32 37
37. M. Rajagopalan, G. Kurian, and J. John Symptom relief with amitriptyline in the irritable bowel syndrome J Gastroenterol Hepatol 13 1998 738 741
38. H. Vahedi, S. Merat, S. Momtahen, A.S. Kazzazi, N. Ghaffari, and G. Olfati Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome Aliment Pharmacol Ther 27 2008 678 684
39. L.J. Brandt, W.D. Chey, A.E. Foxx-Orenstein, L.R. Schiller, P.S. Schoenfeld, and B.M. Spiegel An evidence-based position statement on the management of irritable bowel syndrome Am J Gastroenterol 104 Suppl 1 2009 S1 S35
40. A.C. Ford, N.J. Talley, P.S. Schoenfeld, E.M. Quigley, and P. Moayyedi Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis Gut 58 2009 367 378
41. A.C. Ford, and P. Moayyedi Dyspepsia Curr Opin Gastroenterol 29 2013 662 668
42. S.M. Patel, W.B. Stason, A. Legedza, S.M. Ock, T.J. Kaptchuk, and L. Conboy The placebo effect in irritable bowel syndrome trials: a meta-analysis Neurogastroenterol Motil 17 2005 332 340
43. L. Brunton Agents for control of gastric acidity and treatment of peptic ulcers J.G. Hardman, L.E. Limbird, Goodman and Gilman's, The pharmacological basis for therapeutics 1996 McGraw-Hill New York 901 915
44. B.E. Lacy, N.J. Talley, G.R. Locke III, E.P. Bouras, J.K. DiBaise, and H.B. El-Serag Review article: current treatment options and management of functional dyspepsia Aliment Pharmacol Ther 36 2012 3 15
45. P. Moayyedi, S. Soo, J. Deeks, B. Delaney, M. Innes, and D. Forman Pharmacological interventions for non-ulcer dyspepsia Cochrane Database Syst Rev 2006 CD001960
46. M. Amini, M.E. Ghamar Chehreh, H. Khedmat, G. Valizadegan, M. Babaei, and A. Darvishi Famotidine in the treatment of functional dyspepsia: a randomized double-blind, placebo-controlled trial J Egypt Public Health Assoc 87 2012 29 33
47. M. Igarashi, W.N. May, and G.S. Golden Pharmacologic treatment of childhood migraine J Pediatr 120 1992 653 657
48. P.R. Saxena 5-HT in migraine-an introduction J Neurol 238 Suppl 1 1991 S36 S37
49. E.J. Mylecharane 5-HT2 receptor antagonists and migraine therapy J Neurol 238 Suppl 1 1991 S45 S52
50. S.J. Peroutka, S.B. Banghart, and G.S. Allen Calcium channel antagonism by pizotifen J Neurol Neurosurg Psychiatry 48 1985 381 383
51. M. Worawattanakul, J.M. Rhoads, S.N. Lichtman, and M.H. Ulshen Abdominal migraine: prophylactic treatment and follow-up J Pediatr Gastroenterol Nutr 28 1999 37 40
52. L. Rodriguez, J. Diaz, and S. Nurko Safety and efficacy of cyproheptadine for treating dyspeptic symptoms in children J Pediatr 163 2013 261 267
53. H. Nyhlin, C. Bang, L. Elsborg, J. Silvennoinen, I. Holme, and P. Ruegg A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome Scand J Gastroenterol 39 2004 119 126
54. J. Kellow, O.Y. Lee, F.Y. Chang, S. Thongsawat, M.Z. Mazlam, and H. Yuen An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome Gut 52 2003 671 676
55. J.H. De Maeyer, R.A. Lefebvre, and J.A. Schuurkes 5-HT4 receptor agonists: similar but not the same Neurogastroenterol Motil 20 2008 99 112
56. M.A. Benninga, and E.A. Mayer The power of placebo in pediatric functional gastrointestinal disease Gastroenterology 137 2009 1207 1210
57. B.S. Collins, and H.C. Lin Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain J Pediatr Gastreoenterol Nutr 52 2011 382 386
58. A. Horvath, P. Dziechciarz, and H. Szajewska Glucomannan for abdominal pain-related functional gastrointestinal disorders in children: a randomized trial World J Gastroenterol 19 2013 3062 3068
59. M. Bausserman, and S. Michail The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial J Pediatr 147 2005 197 201
60. R. Francavilla, V. Miniello, A.M. Magista, A. De Canio, N. Bucci, and F. Gagliardi A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain Pediatrics 126 2010 e1445 e1452
61. J.M. Kelley, A.J. Lembo, J.S. Ablon, J.J. Villanueva, L.A. Conboy, and R. Levy Patient and practitioner influences on the placebo effect in irritable bowel syndrome Psychosom Med 71 2009 789 797
62. A.M. Vlieger, C. Menko-Frankenhuis, S.C. Wolfkamp, E. Tromp, and M.A. Benninga Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial Gastroenterology 133 2007 1430 1436
63. J.A. Weydert, D.E. Shapiro, S.A. Acra, C.J. Monheim, A.S. Chambers, and T.M. Ball Evaluation of guided imagery as treatment for recurrent abdominal pain in children: a randomized controlled trial BMC Pediatr 6 2006 29
64. M. Gross, and P. Warschburger Evaluation of a cognitive-behavioral pain management program for children with chronic abdominal pain: a randomized controlled study Int J Behav Med 20 2013 434 443
65. M.R. Sanders, R.W. Shepherd, G. Cleghorn, and H. Woolford The treatment of recurrent abdominal pain in children: a controlled comparison of cognitive-behavioral family intervention and standard pediatric care J Consult Clin Psychol 62 1994 306 314
66. M.A. Duarte, F.J. Penna, E.M. Andrade, C.S. Cancela, J.C. Neto, and T.F. Barbosa Treatment of nonorganic recurrent abdominal pain: cognitive-behavioral family intervention J Pediatr Gastroenterol Nutr 43 2006 59 64
67. R.L. Levy, S.L. Langer, L.S. Walker, J.M. Romano, D.L. Christie, and N. Youssef Cognitive-behavioral therapy for children with functional abdominal pain and their parents decreases pain and other symptoms Am J Gastroenterol 105 2010 946 956
68. R.L. Levy, S.L. Langer, L.S. Walker, J.M. Romano, D.L. Christie, and N. Youssef Twelve-month follow-up of cognitive behavioral therapy for children with functional abdominal pain JAMA Pediatr 167 2013 178 184
69. A.M. Vlieger, J.M. Rutten, A.M. Govers, C. Frankenhuis, and M.A. Benninga Long-term follow-up of gut-directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome Am J Gastroenterol 107 2012 627 631
70. M. Corsetti, and J. Tack FDA and EMA end points: which outcome end points should we use in clinical trials in patients with irritable bowel syndrome? Neurogastroenterol Motil 25 2013 453 457